Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00467467 · ClinicalTrials.gov registry record · Phase 3
Alfuzosin Hydrochloride to Relieve Ureteral Stent Discomfort
A Phase 3 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 3
- Development phase
- 60
- Enrollment target
NCT00467467 is a Phase 3 study that has completed, run by University of Minnesota. The registered enrollment target is 60 participants.
The verdict
NCT00467467, a Phase 3 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 60 participants
- Enrollment target
Study Summary
To assess the impact of alfuzosin vs. placebo on ureteral stent discomfort, urinary symptoms and quality of life.
Interventions
- DRUG Alfuzosin Hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2006-06 |
| Est. Completion | 2007-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00467467
The ClinicalTrials.gov registry entry for NCT00467467 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Alfuzosin Hydrochloride is the first listed.
NCT00467467 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00467467 about?
NCT00467467 is a clinical study titled "Alfuzosin Hydrochloride to Relieve Ureteral Stent Discomfort". To assess the impact of alfuzosin vs. placebo on ureteral stent discomfort, urinary symptoms and quality of life.
What is the current status of trial NCT00467467?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 60 participants. The study started on 2006-06. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00467467?
The interventions under investigation include: Alfuzosin Hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00467467?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.